Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: Efficacy in mycosis fungoides and other non-hodgkin's lymphomas

Timothy M. Kuzel*, Steven T. Rosen, Leo I. Gordon, Jane Winter, Ellen Samuelson, Karen Kaul, Henry H. Roenigk, Pamela Nylen, Thasia Woodworth

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: Efficacy in mycosis fungoides and other non-hodgkin's lymphomas'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science